Umbilical Cord Blood Transplantation in Adults Using Myeloablative and Nonmyeloablative Preparative Regimens
Overview
Authors
Affiliations
Unrelated umbilical cord blood (UCB) transplantation has recently been explored in an increasing number of adult patients. The relative ease of procurement and the lower-than-anticipated risk of severe acute graft-versus-host disease has made UCB transplantation an appealing alternative to bone marrow-derived hematopoietic stem cells. The use of reduced-intensity or nonmyeloablative preparative regimens to allow engraftment of UCB broadens the scope of patients who may benefit from allogeneic immunotherapy, including elderly and medically infirm patients with no matched sibling donor. This review summarizes the available data on the use of UCB as an alternative source of hematopoietic stem cell transplantation in adult patients.
Matsumoto K, Matsuyama T, Sumiyoshi R, Takuji M, Yamamoto T, Shirasaki R J Diabetes Investig. 2022; 14(2):344-347.
PMID: 36321643 PMC: 9889600. DOI: 10.1111/jdi.13939.
Allogeneic hematopoietic cell transplantation for MDS: for whom, when and how?.
Gyurkocza B, Deeg H Blood Rev. 2012; 26(6):247-54.
PMID: 22981712 PMC: 3509173. DOI: 10.1016/j.blre.2012.08.002.
Immune Reactions following Cord Blood Transplantations in Adults.
Narimatsu H Stem Cells Int. 2011; 2011:607569.
PMID: 21716660 PMC: 3118288. DOI: 10.4061/2011/607569.
The immunobiology of cord blood transplantation.
Szabolcs P Korean J Hematol. 2011; 45(4):224-35.
PMID: 21253423 PMC: 3023047. DOI: 10.5045/kjh.2010.45.4.224.
T-lymphocyte recovery and function after cord blood transplantation.
Szabolcs P Immunol Res. 2010; 49(1-3):56-69.
PMID: 21128006 PMC: 3684067. DOI: 10.1007/s12026-010-8194-6.